-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Fluphenazine-d8 Dihydrochloride
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1323633-98-22d.gif)
| Category | SARS-CoV |
| CAS | 1323633-98-2 |
| Description | Flufenazin-[d8] is the labelled analogue of Flufenazin, which is an antipsychotic medication. |
Product Information
| Synonyms | Fluphenazine-d8;Fluphenazine-d8 Dihydrochloride;1323633-98-2;HY-119980S;CS-0608638; |
| IUPAC Name | 2-[2,2,3,3,5,5,6,6-octadeuterio-4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol |
| Molecular Weight | 445.57 |
| Molecular Formula | C22H18D8F3N3OS |
| Canonical SMILES | OCCN(C([2H])([2H])C1([2H])[2H])C([2H])([2H])C([2H])([2H])N1CCCN2C3=CC(C(F)(F)F)=CC=C3SC4=CC=CC=C42 |
| InChI | InChI=1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2/i10D2,11D2,12D2,13D2 |
| InChIKey | PLDUPXSUYLZYBN-BGKXKQMNSA-N |
| Boiling Point | 568.3±50.0°C at 760 mmHg |
| Density | 1.3±0.1 g/cm3 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
